Page 24 - Pharma

Unichem receives approval for donepezil hydrochloride tablets

The product, which is generic version of Eisai's Aricept, is used to improve cognition and behaviour of people with Alzheimer's

Hindusthan National Glass sells German subsidiary for Rs 171 cr

The subsidiary, HNG Global GmbH, posted a turnover of Rs 276 crore during FY 2015-16 and contributed 12 percent of the total consolidated revenue of HNGIL

Global enzymes market to reach $7.2 billion in 2020: Report

While demand for enzymes used in research, biotech and diagnostics is like to post strong gains, the fastest growth will be seen for biocatalysts, particularly used in pharma, says Freedonia report

DCGI grants permission for India's first siRNA drug trial

Biocon and the US-based Quark to start phase II/III study of a novel siRNA (small interfering RNA) drug candidate (QPI-1007) in rare eye disease in India

Lupin receives US FDA nod for generic Activella tablet

Tablet is indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and prevention of postmenopausal osteoporosis

Evonik working on biodegradable composites for medical implants

German firm is conducting research on new biodegradable composite materials for the fixation of fractured bones that will degrade naturally in the body

Snowman Logistics to set up warehouse in Andhra Pradesh

The Krishnapatnam (AP) facility, to be operational by March 2017, will cater to the Exim trade of seafood, meat, dairy products, pharmaceutical products, fruits and fruit pulp

Valeant Pharma to expand Canadian operations

While it will invest $15 million in Steinbach (Manitoba) facility, it will spend $ 12.5 million in Laval (Quebec) facility to increase local manufacturing and export volume

Terumo acquires Sequent Medical for $ 280 mn

The acquisition of US-based developer of new aneurysm embolization device will help Terumo to expand its presence in the global neurovascular device market

US-based Health Alliance to use HGS Colibrium's Tuo Marketplace

Tuo Marketplace will replace Health Alliance Medical Plan's current online enrolment program, and will be leveraged to deliver a superior digital customer experience

Apollo Hospitals to set up hospital in China

The company has tied with Hainan Ecological Smart City Group to build hospital in the Hainan province, where a smart city is being developed in China's largest special economic zone

Introduce data protection as an IPR: Study

The Assocham-TechSci Research study also suggested for digitisation of IPR for pharmaceuticals in India to strengthen online processing

Cipla and Russia's Nacimbio join hands for HIV and hepatitis C drugs

As per the agreement, two sides will collaborate to set up a facility in Russia for the production of antiretroviral drugs

Zydus acquires two drugs from Teva to strengthen US portfolio

The total market size of the two acquired ANDAs (abbreviated new drug applications) is estimated at nearly $ 200 million

Centum Electronics acquires French Adetel Group

The new acquisition strengthens Centum's global design services offering in embedded electronic systems for defence, aerospace, industrial, transportation, medical and energy sectors

Manufacturing CEOs plan aggressive growth strategies: KPMG

While many Western manufacturers talk about a 'sell to China' strategy, respondents from the emerging markets (India and China in particular) are most likely to be investing, says KPMG survey

Zydus Cadila partners with Eczacibasi to tap Turkish biosimilar market

As per the deal, Zydus will market biosimilars, which are currently unavailable in Turkey especially for the treatment of cancer

Ajanta Pharma launches of anti-dementia drug memantine HCl in US

The company has launched the drug, which is a generic version of Forest Laboratories' Namenda tablet, in two strengths - 5 mg & 10 mg tablets

Trelleborg buys Specialty Silicone Fabricators

The acquired company, which manufactures silicone components for the medical device market, is expected to help Trelleborg grow its business in high growth US life sciences market

US specialty pharma firms to change their M&A strategies: Moody's

The slowdown in acquisitions, along with the scrutiny on aggressive price increases, will force many specialty pharmaceutical companies to shift their growth strategies, says the ratings agency